ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
US patent to 2034 granted for Neuren's NNZ-2591 in autism
Published: 11/10/21, 09:50am (AEST)•2 pages